Figures & data
Table 1. Details of included studies
Table 2. Characteristics of included studies comparing ATRA + ATO with ATRA-alone and ATO-alone, ATRA with ATO in the treatment of APL
Figure 1. Forest plots of the CR rate (A), gastrointestinal complications (B) cutaneous reaction (C), encephalalgia (D), and liver injury (E) in ATRA + ATO therapy and ATRA therapy for APL. RR, relative risk; CI, confidence interval.
Figure 2. The meta-analysis of complications in ATRA + ATO therapy and ATO therapy for APL; cutaneous reaction (A), gastrointestinal complications (B), encephalalgia (C), liver injury (D). RR, relative risk; CI, confidence interval.
Figure 3. Comparison of CR rate (A) and liver injury (B) between ATRA group and ATO group. RR, relative risk; CI, confidence interval.
